Stuart Iain
Chief Scientific Officer at Foamix Pharmaceuticals Ltd.
- Sold, on record
- $27k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jul 1, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Foamix Pharmaceuticals Ltd.Chief Scientific Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedAug 8, 2018 2018
Sold 2,715 shares at $5.68 ($15k)
Stuart Iain, SVP R&D
Sold 7.3% of holdings ($210k position)34,285 shares leftFirst sale on recordFiling
- 2 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedNov 8, 2018 +92 days
Sold 683 shares at $4.58 ($3k)
Stuart Iain, SVP R&D
Sold 2% of holdings ($157k position)33,602 shares leftFiling
- 3 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedApr 1, 2019 +144 days
Sold 1,696 shares at $3.75 ($6k)
Stuart Iain, Chief Scientific Officer
Sold 2.6% of holdings ($248k position)64,475 shares leftFiling
- 4 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedJul 1, 2019 +91 days
Sold 951 shares at $2.35 ($2k)
Stuart Iain, Chief Scientific Officer
Sold 1.5% of holdings ($152k position)63,524 shares left0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2019 | Jul 3, 2019 | Foamix Pharmaceuticals Ltd. | Chief Scientific Officer | Form 4 sale | 951 | $2k | 1.5% | Plan not stated | SEC |
| Apr 1, 2019 | Apr 3, 2019 | Foamix Pharmaceuticals Ltd. | Chief Scientific Officer | Form 4 sale | 1,696 | $6k | 2.6% | Plan not stated | SEC |
| Nov 8, 2018 | Nov 13, 2018 | Foamix Pharmaceuticals Ltd. | SVP R&D | Form 4 sale | 683 | $3k | 2.0% | Plan not stated | SEC |
| Aug 8, 2018 | Aug 9, 2018 | Foamix Pharmaceuticals Ltd. | SVP R&D | Form 4 sale | 2,715 | $15k | 7.3% | Plan not stated | SEC |